JENNIFER EASON: Open Payments
NPI 1134762362 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,918 in 128 payments from 34 companies in 2025. Trend: 2023 $2,550 · 2024 $3,389 · 2025 $2,918
Food & beverage: $2,918
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $326 |
| ABBVIE INC. | 6 | $268 |
| Janssen Biotech, Inc. | 9 | $234 |
| E.R. Squibb & Sons, L.L.C. | 11 | $189 |
| AstraZeneca Pharmaceuticals LP | 8 | $175 |
| Daiichi Sankyo Inc. | 7 | $165 |
| PFIZER INC. | 8 | $161 |
| Merck Sharp & Dohme LLC | 7 | $157 |
| Genentech USA, Inc. | 7 | $148 |
| Eisai Inc. | 6 | $108 |
Products named: Venclexta, OPDIVO, RYBREVANT, KISQALI, KEYTRUDA, TAGRISSO, Lenvima, IBRANCE.
Industry payments across KY — which companies pay providers there.
